4h
Zacks.com on MSNBoston Scientific Expects Strong Gains in 2025: Time to Buy the Stock?Boston Scientific Corporation BSX, despite industrywide macroeconomic upheavals, has been seeing strong growth momentum ...
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2024 investor letter. The ...
So far, BSX stock has risen 19% year-to-date. Separately, CROX reports earnings tomorrow. Will the stock pop on the news? See ...
Nations Financial Group Inc. IA ADV trimmed its holdings in Boston Scientific Co. (NYSE:BSX – Free Report) by 5.9% in the ...
3d
GlobalData on MSNBoston Scientific bags CE marking for Farapulse catheter and softwareThe tools ideate on Boston Scientific’s Farapulse PFA system, which contributed towards a 172% uptick in the company’s Q4 ...
Investing.com -- Boston Scientific Corp (NYSE: BSX ). has had its issuer credit rating and its issue-level rating on its senior unsecured debt upgraded to 'A-' from 'BBB+' by S&P Global Ratings. This ...
Argus raised the firm’s price target on Boston Scientific (BSX) to $130 from $105 and keeps a Buy rating on the shares. The firm sees strong ...
At the town hall of the annual gathering of the American Association for the Advancement of Science, Trump’s name was largely ...
Argus Research analyst David Toung maintained a Buy rating on Boston Scientific (BSX – Research Report) on February 14. The company’s shares ...
Boston Scientific announced won CE mark for its navigation-enabled Farawave Nav ablation catheter and Faraview software.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results